FASL -844C polymorphism is associated with increased activation-induced T cell death and risk of cervical cancer. - Wikidata - wikimedia - TriplyDB

FASL -844C polymorphism is associated with increased activation-induced T cell death and risk of cervical cancer.

FASL -844C polymorphism is associated with increased activation-induced T cell death and risk of cervical cancer.

http://www.wikidata.org/entity/Q36403535

about

Apoptosis gene polymorphisms, age, smoking and the risk of non-small cell lung cancer Association of the polymorphisms in the Fas/FasL promoter regions with cancer susceptibility: a systematic review and meta-analysis of 52 studies FAS-1377 G/A (rs2234767) polymorphism and cancer susceptibility: a meta-analysis of 17,858 cases and 24,311 controls The FAS ligand promoter polymorphism, rs763110 (-844C>T), contributes to cancer susceptibility: evidence from 19 case-control studies FASL rs763110 polymorphism contributes to cancer risk: an updated meta-analysis involving 43,295 subjects Interactions among genetic variants in apoptosis pathway genes, reflux symptoms, body mass index, and smoking indicate two distinct etiologic patterns of esophageal adenocarcinoma Association of Fas -1377 G/A polymorphism with susceptibility to cancer Fas and FasL gene polymorphisms are not associated with cervical cancer but differ among Black and Mixed-ancestry South Africans FAS and FASLG genetic variants and risk for second primary malignancy in patients with squamous cell carcinoma of the head and neck.Human FasL gene is a target of β-catenin/T-cell factor pathway and complex FasL haplotypes alter promoter functions.Functional polymorphisms of FAS and FASL gene and risk of breast cancer - pilot study of 134 cases.Lack of association between Fas rs180082 polymorphism and risk of cervical cancer: an update by meta-analysis Functional polymorphisms in FAS/FASL system increase the risk of neuroblastoma in Chinese population Prognostic role of apoptosis-related gene functional variants in advanced non-small-cell lung cancer patients treated with first-line platinum-based chemotherapy.Functional polymorphisms in interleukin-23 receptor and susceptibility to esophageal squamous cell carcinoma in Chinese population.CD95 rs1800682A/G variant and tumor risk in Asians: evidence from a meta-analysis of 36 case-control studies containing 22,438 samples.A comprehensive review on host genetic susceptibility to human papillomavirus infection and progression to cervical cancer.The combined risks of reduced or increased function variants in cell death pathway genes differentially influence cervical cancer risk and herpes simplex virus type 2 infection among black Africans and the Mixed Ancestry population of South Africa A common hereditary single-nucleotide polymorphism in the gene of FAS and colorectal cancer survival.Site disparities in apoptotic variants as predictors of risk for second primary malignancy in patients with squamous cell carcinoma of the head and neck Fas-670A>G polymorphism is not associated with an increased risk of acute myeloid leukemia development Apoptotic variants as predictors of risk of oropharyngeal cancer recurrence after definitive radiotherapy.The association between -1304T>G polymorphism in the promoter of mitogen-activated protein kinase kinase 4 gene and the risk of cervical cancer in Chinese population Molecular profiling of cervical neoplasia.The role of regulatory T cells in the control of natural killer cells: relevance during tumor progression.New approach reveals CD28 and IFNG gene interaction in the susceptibility to cervical cancer.Gene discovery in cervical cancer : towards diagnostic and therapeutic biomarkers.Association of the HLA locus and TNF with type I autoimmune hepatitis susceptibility in New Zealand Caucasians.FAS and FAS-L genotype and expression in patients with recurrent pregnancy loss FAS-670 gene polymorphism and cervical carcinogenesis risk: A meta-analysis.Lack of association between the FAS/FASL polymorphisms and cervical cancer risk: A meta-analysis.Cervical Carcinogenesis and Immune Response Gene Polymorphisms: A Review.FasL gene -844T/C mutation of esophageal cancer in South China and its clinical significance.Genetic susceptibility to cervical cancer: role of common polymorphisms in apoptosis-related genes.A novel mechanism of rs763110 polymorphism contributing to cervical cancer risk by affecting the binding affinity of C/EBPβ and OCT1 complex to chromatin.Association between FAS A670G polymorphism and susceptibility to cervical cancer: evidence from a meta-analysis.Association between FAS and FASL genetic variants and risk of primary brain tumor.Promoter polymorphism of FASL confers protection against female-specific cancers and those of FAS impact the cancers divergently.A genetic IFN/STAT1/FAS axis determines CD4 T stem cell memory levels and apoptosis in healthy controls and Adult T-cell Leukemia patients.Association of a microsatellite in FASL to type II diabetes and of the FAS-670G>A genotype to insulin resistance

P2860

Q23918557-52B7F6C1-3801-48F0-A8DD-FE8450033504 Q26859155-77CDBA1A-9139-4304-8231-A154A23B545B Q26866492-05E2D062-9C0A-4982-ACD6-8FC54CEFD950 Q28384635-30737F84-A666-4154-A272-CEC741F95521 Q28389021-8A1733D2-E497-4F32-8592-557E06D039D7 Q28396031-483EDD96-D9FB-4095-A9C0-4AC7C6DDF084 Q28396240-7A03A7E9-5FBB-4F96-87AE-502062539102 Q33516711-9C9946C8-5ED4-4F06-9B74-8F9EC2399220 Q33903227-0F2A05EF-374E-4F2E-8F42-B1B49E7C3EF7 Q34056050-3B1402E7-AD2D-4C08-979F-54DD75030E9F Q34551169-CB765C52-2649-4D88-8222-AB1D2B448A16 Q34833111-202EEDE8-4848-494E-B752-CD0BC8894A87 Q34950211-B0190A1E-B22E-445A-9261-7B2F75178AF1 Q34982250-238E9B85-D6FD-49B6-828A-0A2ACA33DE72 Q35106676-E1BF5672-1B89-47CC-89A2-F00FA27613DD Q35161687-0616F8C1-4D0E-4EA8-9349-7FC98128E9CF Q35749285-F010564D-4932-40DB-A9E7-5373767E8FA1 Q35803679-ACF3A2C0-84C9-41F6-B822-94D0ED02C957 Q35893369-BC749372-06D8-49B0-93D3-7C9EE96043C6 Q35917835-ED5E794C-4C08-4B1E-A791-A2A6E5629BBD Q35928161-CC461F85-39E4-461B-8B65-9B72E5EA6B3E Q36075038-6E7F1F57-49D1-4106-AD9E-BB5B912696CF Q36081343-EBEF8E9B-F27D-4D5E-9BDE-9AE4A3ECA21C Q36411685-DDB618C1-DBAC-4395-8093-80EE0C35CF66 Q36652214-1E860917-A27D-48D4-A500-C501B28A2AF9 Q36877132-D0281958-0F45-4DBA-A63F-904FFDFC4453 Q36982644-ED411F2E-838F-4EF1-95F4-A781E1562D24 Q37068979-BB30F52A-F7F4-4AD0-B7D9-8F1F657B36CA Q37100571-3D09D16F-4FBA-44E3-9645-305088C68E34 Q37565239-AE9A54E6-4016-4911-ABA9-E13F506610E1 Q37565343-67F20251-8783-486B-821D-ED10409E56C2 Q37661158-4CDE91B2-50B5-4E2C-897C-E33F19A79CE1 Q37736549-2BDEE98F-142B-4AA9-9255-9499D515F49C Q38560697-55DDA237-64DE-4CB8-864C-1997F5203BB7 Q39240273-0EAF1904-1460-4FE0-A643-A84DE404E46F Q47896302-C6F5BB0F-940E-40AA-82AF-3F3399C00726 Q48957904-74E4A1A7-C117-4817-8CC8-200EEB4E0386 Q51071316-41E03D4E-0008-4AB2-BC08-B48423A4D9AC Q55231926-C689635A-03BE-4D0E-8B15-D6D99D9CFB6C Q58201197-8616E83E-3F39-4894-B659-977E86723CE4

P2860

FASL -844C polymorphism is associated with increased activation-induced T cell death and risk of cervical cancer.

http://www.wikidata.org/entity/Q36403535

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

FASL -844C polymorphism is ass ...... h and risk of cervical cancer.

@ast

FASL -844C polymorphism is ass ...... h and risk of cervical cancer.

@en

type

label

FASL -844C polymorphism is ass ...... h and risk of cervical cancer.

@ast

FASL -844C polymorphism is ass ...... h and risk of cervical cancer.

@en

prefLabel

FASL -844C polymorphism is ass ...... h and risk of cervical cancer.

@ast

FASL -844C polymorphism is ass ...... h and risk of cervical cancer.

@en

P1433

Q36403535-B92160C4-9256-4FDA-B68A-95F36DC4C413

P1476

Q36403535-5F319EA4-8CD3-4828-9BCF-3ED6A257FED1

P2093

Q36403535-3E009F53-AF85-4258-AF94-F29686F77B3B

Q36403535-584F67CB-B8B3-4342-9CA1-A0108A65DB49

Q36403535-73BFFADC-1486-4679-8B1D-85852730BC9B

Q36403535-891C9D44-A1DD-4205-8F51-7A885AC7A75F

Q36403535-95DC825A-8158-40D1-8E09-D089789A7E58

Q36403535-96E4B9F8-A7DB-4407-87AE-CD0940980089

Q36403535-98338108-1E30-4DB6-A795-D367A88F9001

Q36403535-A1F9F7B5-3E87-4366-86C2-91C80645B0D9

Q36403535-BEA04C89-E9EA-4285-B141-F5CAB819DD04

Q36403535-C7431048-E1D6-4D9F-912C-E8A7AB5A74E1

P2860

Q36403535-03646592-E4DF-436C-95A4-1CA05402956A

Q36403535-16BADC50-8001-43C5-A2D2-E38E829BE7D9

Q36403535-190B7400-D4CA-45C3-8F1E-5793B4DC860C

Q36403535-24A26AA3-438C-4733-95EF-E28100FFBD8E

Q36403535-303CB644-CB39-4F14-95D3-F406AA0D5508

Q36403535-3212776C-3607-4AB4-9744-6892492C8B58

Q36403535-407EE3CC-F40F-4CF8-A7BB-F6AD18C53DF8

Q36403535-46B69A48-35AF-4E3F-BF73-B9B0B239C2FE

Q36403535-4ADAD052-2132-446F-A2C1-5732D015C4D6

Q36403535-54CF41BE-E007-4CD2-B0DB-F22FDEAA8CD1

P304

Q36403535-23652674-23CA-4F8B-B482-B13587739CEA

P31

Q36403535-743173E7-EC1B-4DAA-89CF-A15DF41A3540

P356

Q36403535-8A03A2FC-AC79-4F3B-BD8D-89B510D1766F

P407

Q36403535-D3345912-CC2D-422D-BF58-735967539513

P433

Q36403535-17EC5E65-B201-4BA3-A1DB-D2731E48AFED

P478

Q36403535-95372211-BC22-4C9E-965F-C10CD663023F

P50

Q36403535-33E7EA32-E562-4594-9F84-BC379B7052C9

P577

Q36403535-DAEADDC4-9B83-489F-A53F-B9A5BB5F1B29

P5875

Q36403535-2FD7812D-3B8F-453E-A314-2DD1994AAE61

P698

Q36403535-5E23C18E-3E50-475E-B25E-C8E778056751

P932

Q36403535-5923AB69-BB39-4113-A235-33F4341B113D

P356

P1433

Journal of Experimental Medicine

P1476

FASL -844C polymorphism is ass ...... th and risk of cervical cancer

@en

P2093

Dongxin Lin

http://www.w3.org/2001/XMLSchema#string

Hua Li

http://www.w3.org/2001/XMLSchema#string

Li Wang

http://www.w3.org/2001/XMLSchema#string

Tong Sun

http://www.w3.org/2001/XMLSchema#string

Wen Tan

http://www.w3.org/2001/XMLSchema#string

Xiaohong Han

http://www.w3.org/2001/XMLSchema#string

Xiaoping Miao

http://www.w3.org/2001/XMLSchema#string

Xuemei Zhang

http://www.w3.org/2001/XMLSchema#string

Yifeng Zhou

http://www.w3.org/2001/XMLSchema#string

Yongli Guo

http://www.w3.org/2001/XMLSchema#string

P2860

The integration of HPV-18 into HeLa cells has involved duplication of part of the viral genome as well as human DNA flanking sequences

A New Statistical Method for Haplotype Reconstruction from Population Data

The regulation of FasL expression during activation-induced cell death (AICD)

Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

Identification of a naturally processed HLA-A*0201 HPV18 E7 T cell epitope by tumor cell mediated in vitro vaccination.

HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity.

Activation-induced cell death: the controversial role of Fas and Fas ligand in immune privilege and tumour counterattack.

Activation-induced cell death in T cells.

Activation-induced apoptosis in lymphoid systems.

P304

967-974

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1084/JEM.20050707

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

202

http://www.w3.org/2001/XMLSchema#string

P50

P577

2005-09-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7578601

http://www.w3.org/2001/XMLSchema#string

P698

16186185

http://www.w3.org/2001/XMLSchema#string

P932

2213165

http://www.w3.org/2001/XMLSchema#string